MeSH Browser

MeSH Heading: Ad26COVS1
Tree Number(s): D20.215.894.899.085.125
Unique ID: D000090984
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000090984
Scope Note: A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
Entry Term(s): Ad26.COV2.S; COVID-19 Vaccine Johnson & Johnson; JNJ 78436735; JNJ-78436735; Johnson & Johnson Covid-19 Vaccine
Registry Numbers: JT2NS6183B; 0
Public MeSH Note: 2022; AD26COVS1 was indexed under COVID-19 VACCINES 2021
History Note: 2022
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2021/12/02

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M000742885
Registry Numbers: JT2NS6183B
Scope Note: A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
Terms: Ad26COVS1 Preferred Term
Term UI T001094954
Date01/15/2021
LexicalTag NON
ThesaurusID NLM (2021); COVID-19 Vaccine Johnson & Johnson
Term UI T001105740
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); Ad26.COV2.S
Term UI T001095868
Date01/28/2021
LexicalTag NON
ThesaurusID NLM (2021); Johnson & Johnson Covid-19 Vaccine
Term UI T001115266
Date12/02/2021
LexicalTag NON
ThesaurusID NLM (2022)

Ad26COVS1 MeSH Descriptor Data 2025